FEINSTEIN ELENA has a total of 46 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are IDERA PHARMACEUTICALS, CHANGCHUN HUAPU BIOTECHNOLOGY and OMNICYTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 36 | |
#2 | WIPO (World Intellectual Property Organization) | 10 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Agriculture | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Enzymes | |
#6 | Peptides | |
#7 | Animal care | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Feinstein Elena | 46 |
#2 | Mett Igor | 24 |
#3 | Kalinski Hagar | 18 |
#4 | Skaliter Rami | 9 |
#5 | Ehrlich Shai | 3 |
#6 | Alpert Evgenia | 3 |
#7 | Giese Klaus | 3 |
#8 | Erlich Shai | 3 |
#9 | Adamsky Svetlana | 3 |
#10 | Kaufmann Jorg | 3 |
Publication | Filing date | Title |
---|---|---|
US2011288155A1 | Sirna compounds and methods of use thereof | |
WO2009074990A2 | Rtp801l sirna compounds and methods of use thereof | |
US2011190380A1 | Methods for delivery of sirna to bone marrow cells and uses thereof | |
WO2009001359A2 | Compositions and methods for inhibiting expression of pro-apoptotic genes | |
WO2008126085A2 | Method for treating bone marrow disorders | |
US2010292301A1 | Novel sirna structures | |
WO2008050329A2 | Novel sirnas and methods of use thereof | |
US2010272722A1 | Therapeutic uses of inhibitors of RTP801 | |
WO2006131925A2 | Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |